Universal Ibogaine Inc. (IBOGF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -10.49 Million CAD | -171.41% |
| 2021 | -3.86 Million CAD | -3168.74% |
| 2020 | -118.3 Thousand CAD | -20.59% |
| 2019 | -98.1 Thousand CAD | 75.97% |
| 2018 | -408.28 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -792.85 Thousand CAD | 5.83% |
| 2023 Q1 | -841.96 Thousand CAD | 87.15% |
| 2023 Q3 | -486.59 Thousand CAD | 38.63% |
| 2022 Q4 | -6.55 Million CAD | -458.21% |
| 2022 FY | -10.49 Million CAD | -171.41% |
| 2022 Q3 | -1.17 Million CAD | -12.87% |
| 2022 Q2 | -1.03 Million CAD | 39.93% |
| 2022 Q1 | -1.73 Million CAD | -7373.61% |
| 2021 Q3 | -83.42 Thousand CAD | -0.41% |
| 2021 FY | -3.86 Million CAD | -3168.74% |
| 2021 Q1 | -69.58 Thousand CAD | -27.54% |
| 2021 Q4 | -23.16 Thousand CAD | 72.23% |
| 2021 Q2 | -83.08 Thousand CAD | -19.4% |
| 2020 Q1 | -30.82 Thousand CAD | -3.36% |
| 2020 Q2 | -22.15 Thousand CAD | 28.11% |
| 2020 Q4 | -54.55 Thousand CAD | -53.62% |
| 2020 FY | -118.3 Thousand CAD | -20.59% |
| 2020 Q3 | -35.51 Thousand CAD | -60.28% |
| 2019 Q3 | -18.19 Thousand CAD | 33.64% |
| 2019 FY | -98.1 Thousand CAD | 75.97% |
| 2019 Q4 | -29.81 Thousand CAD | -63.84% |
| 2019 Q2 | -27.42 Thousand CAD | -49.09% |
| 2019 Q1 | -18.39 Thousand CAD | 46.05% |
| 2018 Q2 | -98.44 Thousand CAD | 44.58% |
| 2018 Q1 | -177.61 Thousand CAD | -84.11% |
| 2018 Q3 | -35.76 Thousand CAD | 63.67% |
| 2018 Q4 | -34.09 Thousand CAD | 4.68% |
| 2018 FY | -408.28 Thousand CAD | 0.0% |
| 2017 Q4 | -96.47 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bioxytran, Inc. | -4.28 Million USD | -145.238% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 85.998% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -3739.109% |
| SQZ Biotechnologies Company | -79.46 Million USD | 86.791% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -262.89% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 119.812% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 116.115% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -476.547% |
| Marizyme, Inc. | -65.34 Million USD | 83.938% |
| Genus plc | 7.9 Million USD | 232.863% |
| Pharming Group N.V. | -10.54 Million USD | 0.491% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -383.737% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -182.899% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -18.682% |
| ContraFect Corporation | -65.15 Million USD | 83.89% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -507.611% |
| IMV Inc. | -36.48 Million USD | 71.232% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -30.231% |
| ONE Bio Corp. | 8.67 Million USD | 220.971% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 79.695% |
| Mesoblast Limited | -87.95 Million USD | 88.067% |
| MultiCell Technologies, Inc. | -380.07 USD | -2761549.696% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -181.173% |
| Genscript Biotech Corporation | -95.47 Million USD | 89.007% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1559.723% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -340.856% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -59.611% |
| Biomind Labs Inc. | -1.21 Million USD | -764.369% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -238.394% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -32.811% |
| Skye Bioscience, Inc. | -37.64 Million USD | 72.118% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -438.474% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 3.632% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -69986.819% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -114.819% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -50.314% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 33.867% |
| Accustem Sciences Inc. | -3.74 Million USD | -180.166% |
| EV Biologics, Inc. | -1.26 Million USD | -728.342% |
| Q BioMed Inc. | -2.05 Million USD | -411.488% |
| GB Sciences, Inc. | -1.36 Million USD | -670.829% |
| Alpha Cognition Inc. | -13.77 Million USD | 23.789% |
| CSL Limited | 2.64 Billion USD | 100.397% |
| Agentix Corp. | -1.37 Million USD | -663.798% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 82.426% |
| Enzolytics Inc. | -2.17 Million USD | -382.178% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -3.61 Million USD | -190.754% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -230.961% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -80.432% |
| argenx SE | -295.05 Million USD | 96.443% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 83.233% |
| HST Global, Inc. | -146.21 Thousand USD | -7078.854% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 10810.41% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -498.152% |
| Halberd Corporation | -79.67 Thousand USD | -13073.606% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 251.579% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -246.852% |
| Zenith Capital Corp. | -10.59 Million USD | 0.942% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -164.189% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -153.168% |
| AVAX Technologies, Inc. | -6.41 Million USD | -63.654% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -17266.142% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -423.471% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -45060.494% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -120.084% |
| Helix BioMedix, Inc. | -1.05 Million USD | -893.905% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -174.842% |
| Kadimastem Ltd | -3.3 Million USD | -217.355% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -23.732% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -2278.101% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -685.979% |
| LadRx Corporation | 400.44 Thousand USD | 2721.148% |
| Cell Source, Inc. | -5.32 Million USD | -97.252% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -2426.289% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1125.512% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1125.512% |
| Affymax, Inc. | -14.42 Million USD | 27.231% |
| Mobile Lads Corp. | -2.26 Million USD | -363.758% |
| Itoco Inc. | -1.86 Million USD | -461.596% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -136.266% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -528.892% |
| International Stem Cell Corporation | -131 Thousand USD | -7912.368% |
| CytoDyn Inc. | -49.84 Million USD | 78.941% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -13180.784% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -4501.035% |
| Qrons Inc. | -789.34 Thousand USD | -1229.732% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1014.804% |
| SYBLEU INC | -180.3 Thousand USD | -5721.392% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -402.768% |
| Rebus Holdings, Inc. | -1.02 Million USD | -929.039% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -550.832% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -19239.995% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -314.829% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 78.166% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -396.509% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -1244.138% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -231.32% |
| Neutra Corp. | -233.46 Thousand USD | -4395.835% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 48.272% |
| PureTech Health plc | -65.69 Million USD | 84.023% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 50.645% |
| IXICO plc | -1.17 Million USD | -791.019% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -5.734% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 81.627% |
| CSL Limited | 2.64 Billion USD | 100.397% |
| Cellectis S.A. | -103.17 Million USD | 89.827% |